EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transformed astrocytes confer temozolomide resistance on glioblastoma via delivering ALKBH7 to enhance APNG expression after educating by glioblastoma stem cells‐derived exosomes

Xinglei Liu, Liang Liu, Anyi Wu, Shilu Huang, Zhipeng Xu, Xiaopei Zhang, Zengyang Li, Haoran Li, Jun Dong iD

CNS Neuroscience & Therapeutics · 2024

DOI: 10.1111/cns.14599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Xinglei Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Exosomes, Glioblastoma. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu province key research and development program: Social development project, Key project of Jiangsu Health Commission, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma is the most malignant primary brain tumor in adults. Temozolomide (TMZ) stands for the first‐line chemotherapeutic agent against glioblastoma. Nevertheless, the therapeutic efficacy of TMZ appears to be remarkably limited, because of low cytotoxic efficiency against glioblastoma. Besides, various mechanical studies and the corresponding strategies fail to enhancing TMZ curative effect in clinical practice. Our previous studies have disclosed remodeling of glial cells by GSCs, but the roles of these transformed cells on promoting TMZ resistance have never been explored.

Methods

Exosomes were extracted from GSCs culture through standard centrifugation procedures, which can activate transformation of normal human astrocytes (NHAs) totumor‐associated astrocytes (TAAs) for 3 days through detect the level of TGF‐β, CD44 and tenascin‐C. The secretive protein level of ALKBH7 of TAAs was determined by ELISA kit. The protein level of APNG and ALKBH7 of GBM cells were determined by Western blot. Cell‐based assays of ALKBH7 and APNG triggered drug resistance were performed through flow cytometric assay, Western blotting and colony formation assay respectively. A xenograft tumor model was applied to investigate the function of ALKBH7 in vivo. Finally, the effect of the ALKBH7/APNG signaling on TMZ resistance were evaluated by functional experiments.

Results

Exosomes derived from GSCs can activate transformation of normal human astrocytes (NHAs)to tumor‐associated astrocytes (TAAs), as well as up‐regulation of ALKBH7expression in TAAs. Besides, TAAs derived ALKBH7 can regulate APNG gene expression of GBM cells. After co‐culturing with TAAs for 5 days, ALKBH7 and APNG expression in GBM cells were elevated. Furthermore, Knocking‐down of APNG increased the inhibitory effect of TMZ on GBM cells survival.

Conclusion

The present study illustrated a new mechanism of glioblastoma resistance to TMZ, which based on GSCs‐exo educated TAAs delivering ALKBH7 to enhance APNG expression of GBM cells, which implied that targeting on ALKBH7/APNG regulation network may provide a new strategy of enhancing TMZ therapeutic effects against glioblastoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsExosomesGlioblastomaAdultHumansAlkB EnzymesAntineoplastic Agents, AlkylatingAstrocytesCell Line, TumorDrug Resistance, NeoplasmMitochondrial ProteinsStem CellsTemozolomideXenograft Model Antitumor AssaysDNA Glycosylases

Stichwörter der Autor:innen

ALKBH7APNGTMZ resistanceglioblastomaglioblastoma stem cells-derived exosomestumor-associated astrocytes

Substanzen

AlkB EnzymesAntineoplastic Agents, AlkylatingMitochondrial ProteinsTemozolomideALKBH7 protein, humanMPG protein, humanDNA Glycosylases

Autor:innen und Institutionen

  • Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Department of Neurosurgery, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.

ORCID-Profile: Jun Dong

Förderung

  • Jiangsu province key research and development program: Social development project
  • Key project of Jiangsu Health Commission
  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China

Zitieren

APA

Liu, X., Liu, L., Wu, A., Huang, S., Xu, Z., Zhang, X., Li, Z., Li, H., & Dong, J. (2024). Transformed astrocytes confer temozolomide resistance on glioblastoma via delivering ALKBH7 to enhance APNG expression after educating by glioblastoma stem cells‐derived exosomes. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14599

Vancouver

Liu X, Liu L, Wu A, Huang S, Xu Z, Zhang X, et al. Transformed astrocytes confer temozolomide resistance on glioblastoma via delivering ALKBH7 to enhance APNG expression after educating by glioblastoma stem cells‐derived exosomes. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14599

BibTeX
@article{Liu2024,
  author = {Liu, Xinglei and Liu, Liang and Wu, Anyi and Huang, Shilu and Xu, Zhipeng and Zhang, Xiaopei and Li, Zengyang and Li, Haoran and Dong, Jun},
  title = {Transformed astrocytes confer temozolomide resistance on glioblastoma via delivering ALKBH7 to enhance APNG expression after educating by glioblastoma stem cells‐derived exosomes},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  doi = {10.1111/cns.14599}
}
Kostenlos starten →